ChemicalBook >> CAS DataBase List >>4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-

4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-

CAS No.
934005-36-4
Chemical Name:
4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-
Synonyms
Protectin D1 methyl ester;4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-
CBNumber:
CB012281075
Molecular Formula:
C23H34O4
Molecular Weight:
374.51
MDL Number:
MOL File:
934005-36-4.mol
Last updated:2023-06-08 09:03:09

4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- Properties

Boiling point 516.5±50.0 °C(Predicted)
Density 1.014±0.06 g/cm3(Predicted)
solubility Ethanol: 1 mg/ml
pka 13.75±0.20(Predicted)

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS02,GHS07
Signal word  Danger
Hazard statements  H225-H319
Precautionary statements  P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P337+P313-P370+P378-P403+P235-P501
NFPA 704
3
2 0

4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- Chemical Properties,Uses,Production

Description

Protectin D1 methyl ester is an esterified form of the specialized pro-resolving mediator protectin D1 . It is an intermediate in the synthesis of protectin D1.1 Protectin D1 methyl ester (333 μg/kg) reduces infarct area and volume and increases blood vessel density in the tissue surrounding the infarct in a rat model of ischemic stroke induced by middle cerebral artery occlusion (MCAO).2

References

1. Rodriguez, A.R., and Spur, B.W. Total synthesis of the potent anti-inflammatory lipid mediator Protectin D1 Tetrahedron Lett. 55(43),6011-6015(2014).
2. Bazan, N.G., Eady, T.N., Khoutorova, L., et al. Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke Exp. Neurol. 236(1),122-130(2012).

4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- Preparation Products And Raw materials

Raw materials

Preparation Products

4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 8739 58
4,7,11,13,15,19-Docosahexaenoic acid, 10,17-dihydroxy-, methyl ester, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- Protectin D1 methyl ester 934005-36-4